¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"heat loss"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • loss
    »ó½Ç, ¼Õ½Ç, ¼Ò½Ç
  • loss-of-function mutation
    ±â´É¼Ò½Çµ¹¿¬º¯ÀÌ
  • mixed hearing loss
    È¥ÇÕ³­Ã»
  • neonatal hair loss
    ½Å»ý¾ÆÅ»¸ð
  • noise induced hearing loss
    ¼ÒÀ½³­Ã»
  • occupational hearing loss
    Á÷¾÷³­Ã»
  • obligatory water loss
    ÇÊ¿¬¼öºÐ¼Õ½Ç
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • radiation loss
    ¹æ»ç¼±¼Õ½Ç
  • speech hearing loss
    ¾îÀ½Ã»·Â¼Õ½Ç, ¸»¼Ò¸®Ã»·Â¼Õ½Ç
  • sensorineural hearing loss
    °¨°¢½Å°æ³­Ã»
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • vitreous loss
    À¯¸®Ã¼Å»Ãâ
  • conductive heat
    Àüµµ¿­
  • convection heat
    ´ë·ù¿­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mixed hearing loss
    È¥ÇÕ³­Ã»
  • noise induced hearing loss
    ¼ÒÀ½³­Ã»
  • occupational hearing loss
    Á÷¾÷³­Ã»
  • perceptive hearing loss
    °¨À½³­Ã», Áö°¢³­Ã»
  • retrolabyrinthine hearing loss
    ¹Ì·ÎµÚ³­Ã»
  • sensorineural hearing loss
    °¨°¢½Å°æ³­Ã»
  • speech hearing loss
    ¾îÀ½Ã»·Â¼Õ½Ç, ¸»¼Ò¸®Ã»·Â¼Õ½Ç
  • insensible loss
    ºÒ°¨»ó½Ç
  • ionization loss
    ÀÌ¿ÂÈ­¼Õ½Ç
  • loss
    ¼Õ½Ç
  • loss mutation
    »ó½Çµ¹¿¬º¯ÀÌ
  • neonatal hair loss
    ½Å»ý¾ÆÅ»¸ð
  • obligatory water loss
    ÇÊ¿¬¼öºÐ¼Õ½Ç
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • radiation loss
    ¹æ»ç¼±¼Õ½Ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hearing loss, perceptive
    °¨À½³­Ã»
  • hearing loss, sensorineural
    °¨°¢½Å°æ¼º ³­Ã»
  • hearing loss, speech
    ¾îÀ½Ã»·Â¼Õ½Ç
  • heating loss
    °¡¿­°¨·®(¡­ÊõåÖ).
  • high velocity signal loss
    °í¼Óµµ ½ÅÈ£ ¼Ò½Ç
  • idiopathic sudden hearing loss
    Ư¹ß¼º µ¹¹ß(¼º)³­Ã»
  • insensible loss
    ºÒ°¨»ó½Ç(¡­ßÃã÷).
  • insensible water loss
    ºÒ°¨¼º(ÝÕÊïàõ) ¼öºÐ»ó½Ç(â©ÝÂßÃã÷).
  • radiation loss
    ¹æ»ç¼±¼Õ½Ç
  • Heat
    ¿­(æð)
  • Heat receptors
    ¿­¼ö¿ëü(æðâ¥é»ô÷)
  • Heat shock protein
    ¿­¼ï´Ü¹éÁú
  • Heat stroke
    ¿­»çº´(æðÞÒÜ»)
  • Initial heat
    Ãʱ⿭(ôøÑ¢æð)
  • adsorption heat
    ÈíÂø¿­.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • congenital hearing loss
    ³­Ã»
  • discrimination loss
    ¾îÀ½ÆÇº°¼Õ½Ç
  • economic loss
    °æÁ¦Àû ¼Õ½Ç.
  • evaporation loss
    Áõ¹ß¼Õ½Ç(¡­áßã÷).
  • functional hearing loss
    ±â´É(¼º) ³­Ã»
  • gastrointestinal loss
  • hearing loss
    °¨°¢½Å°æ(¼º) ³­Ã»
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç, û·ÂÀå¾Ö
  • hearing loss, audiometric
    û·Â¼Õ½Ç
  • hearing loss, central
    ÁßÃß¼º û·Â¼Ò½Ç, ÁßÃß¼º ³­Ã»
  • hearing loss, conductive
    ÀüÀ½¼º ³­Ã», Àüµµ¼º ³­Ã»
  • hearing loss, congenital hereditary
    ¼±Ãµ(¼º) À¯Àü¼º ³­Ã»
  • hearing loss, familial pregressive
    °¡Á· ÁøÇà(¼º) ³­Ã»
  • hearing loss, functional
    ±â´É(¼º) ³­Ã»
  • hearing loss, idiopathic sudden
    Ư¹ß¼º µ¹¹ß(¼º)³­Ã»
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • resting heat
    È޽Ŀ­(æð)
  • specific heat
    ºñ¿­(Ýïæð)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CHV canine herpes virus; centigrade heat unit
Cv specific heat at constant volume
EHP di-(20-ethylhexyl) hydrogen phosphate; Environmental Health Perspectives; excessive heat production;...
HAG heat-aggregated globulin
HBCG heat-aggregated Calmette-Guerin bacillus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EBL Estimated blood loss
EWL Evaporative water loss
EWL Excess Weight Loss
G-LOC G(z)-induced loss of consciousness
HL Hearing loss
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • loss of structural integrity
    ±¸Á¶ÀûÀÎ ¿ÏÀü¼ºÀÇ »ó½Ç
  • patchy loss
    ¹Ý¼º »ó½Ç
  • sensorineural hearing loss
    °¨°¢ ½Å°æ¼º ³­Ã»
  • sensory hearing loss
    °¨°¢¼º ³­Ã»
    ¿Í¿ì
  • signal loss
    ½ÅÈ£ ¼Ò½Ç
  • weight loss
    üÁß °¨¼Ò
    ´Ü½Ä, ½ÄÀÌÁ¶Àý, º´À¸·Î ÀÎÇØ ³ªÅ¸³ª¸ç, üÁö¹æÀÇ °¨¼Ò ¶Ç´Â À½½Ä¼·Ãë ºÎÁ·À¸·Î ÀÎÇÑ ¿µ¾ç°áÇÌ ½Ã¿¡ ³ªÅ¸³­´Ù.
  • brief noxious heat pulse
    ´Ü¼ø À¯ÇØ ¿­ ÆÄµ¿
  • conductive heat
    Àüµµ¿­
  • dry heat sterilization
    °Ç¿­ ¸ê±Õ¹ý
  • heat-stable enterotoxin
    ³»¿­¼º Àå µ¶¼Ò
  • harden heat treatment
    °æÈ­ ¿­ ó¸®
    ¿¬È­µÈ ÇÕ±ÝÀ» ½Ãȿó¸® ÇÏ¸é ±ÔĢȭµÈ ÃʰÝÀÚ°¡ Çü¼ºµÇ¾î °­µµ¿Í °æµµ°¡ Áõ°¡ÇÏ°í ¿¬¼ºÀÌ °¨¼ÒÇÏ´Â °Í.
  • heat
    ¹ß¿­, ¿­, ¿Â¿­, ¿Â¿­¹ý, ¹ßÁ¤
    1. ¿Âµµ »ó½Â °¨°¢. 2. ¿­°¨À» ÀÏÀ¸Å°´Â ¿¡³ÊÁö. ºÐÀÚ È¤Àº ¿øÀÚÀÇ Áøµ¿ÀÇ ÇüÀ¸·Î Á¸ÀçÇÏ¸ç ¹°Áú¿¡ ÀÇÇØ ÀüµµµÈ´Ù. ¹°Áú¿¡ ÀÇÇÑ ´ë·ù, ÀüÀÚÆÄ¿¡ ÀÇÇÑ ¹æ»ç µî¿¡ ÀÇÇØ À̵¿ÇÑ´Ù. 3. ¿ÂµµÀÇ ±â¿ï±â¿¡ ÀÇÇØ À̵¿ÇÏ´Â ¿¡³ÊÁö. 4. ¹ßÁ¤.
  • heat and cold therapy
    ³Ã¿Â ¿ä¹ý
    Â÷°¡¿î ÆÐµå¿Í ¶ß°Å¿î ÆÐµå¸¦ ¹ø°¥¾Æ°¡¸ç º´¼Ò¿¡ ´ë°í Ç÷¾× ¼øÈ¯À» ÃËÁø½Ã۰í ÅëÁõÀ» ¿ÏÈ­½ÃŰ´Â ¹æ¹ý.
  • heat capacity
    ¿­ ¿ë·®
    ¾î¶² ¹°Ã¼ÀÇ ¿Âµµ¸¦ 1 ¡É ³ôÀÌ´Â µ¥ ÇÊ¿äÇÑ ¿­·®. ¹°Ã¼ÀÇ ¿Âµµ°¡ ¾ó¸¶³ª ½±°Ô º¯ÇÏ´À³Ä¸¦ ³ªÅ¸³»´Â ¾çÀ¸·Î¼­ °¡·É ¿­ ¿ë·®ÀÌ Å« ¹°Ã¼´Â ¿Âµµ°¡ Àß º¯ÇÏÁö ¾Ê´Â ¹Ý¸é ¿­ ¿ë·®ÀÌ ÀÛÀº ¹°Ã¼´Â Á¶±Ý¸¸ ¿­À» °¡°¨Çصµ ½±°Ô ¿Âµµ º¯È­¸¦ ÀÏÀ¸Å°°Ô µÈ´Ù. ±× °ªÀº Áú·®¿¡ ºñ·ÊÇϸç, ´ÜÀ§ Áú·®ÀÇ ¿­ ¿ë·®Àº °¢ ¹°Áú °íÀ¯ÀÇ °ªÀ¸·Î ³ªÅ¸³ª´Âµ¥, À̰ÍÀ» ±× ¹°ÁúÀÇ ºñ¿­À̶ó°í ÇÑ´Ù. Áï ¾î¶² ¹°Ã¼ÀÇ ¿­ ¿ë·®Àº ºñ¿­°ú Áú·®À» °öÇÑ °ÍÀ̶ó ÇÒ ¼ö ÀÖ´Ù.
  • heat cramp
    ¿­ °æ·Ã
    ¼ö¾×°ú ÀüÇØÁúÀÇ ºÎÁ·À¸·Î °ñ°Ý±Ù¿¡¼­ °æ·ÃÀÌ ÀϾ´Â °ÍÀ» ¸»ÇÏ´Â µ¥, °æ·ÃÀº ¼Óµµ°¡ ´À¸®¸ç ÅëÁõÀ» µ¿¹ÝÇÑ´Ù. ½ÉÇÑ °æ·ÃÀÌ 1-3ºÐ µ¿¾È Áö¼ÓµÇ±âµµ Çϴµ¥ ´ëü·Î °úÁßÇÏ°Ô »ç¿ëÇÑ ±ÙÀ°¿¡¼­ ÀϾ´Ù. ¿­ °æ·ÃÀº ¹ßÇÑÀ¸·Î ¼öºÐ ¼Õ½ÇÀÌ ÀÖÀ» °æ¿ì ÀüÇØÁúÀÇ º¸Ãæ¾øÀÌ ¹°¸¸À» °ø±ÞÇÏ¿´À» ¶§ ÀϾ´Ù. ÇǺδ Â÷°©°í ÃàÃàÇÏ¸ç ±ÙÀ°¿¡´Â ¾ÐÅëÀÌ ÀÖ´Ù. ±Ù ¿¬Ã൵ º¼ ¼ö ÀÖ´Ù. ÀǽÄÀº ¸í·áÇÏ°í »ýü Ȱ·Â ¡Èĵµ Á¤»óÀÌÁö¸¸ ºÒ¾ÈÇØÇÏ¸ç µ¿ÅëÀ» È£¼ÒÇϱ⵵ ÇÑ´Ù. ü¿ÂÀº Á¤»óÀ̰ųª ¾à°£ »ó½ÂµÇ¸ç, ÀÌȯµÈ ±ÙÀ°Àº µüµüÇÏ°í ¹¶ÃÄÁ® ÀÖ´Ù. Áõ»óÀÌ ³ªÅ¸³ª±â Àü¿¡ ȯÀÚ´Â ¸Å¿ì °Ý·ÄÇÑ ¿îµ¿À» ÇÑ °æ·ÂÀÌ ÀÖ´Ù. ÀÓ»ó º´¸® °Ë»ç »ó Ç÷û ³ªÆ®·ý ³óµµ°¡ ³·°í Ç÷¾×Àº ³óÃàµÈ ¼Ò°ßÀ» º¸ÀδÙ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
hearing loss, partial A condition in which the sense of hearing, although defective, is functional with or without a hearing aid. The hearing level for speech is approximately 40-70 decibels I.s.o. (international organization for standardization) or 30-60 db a.s.a. (american standards association).
(12 Dec 1998)
hearing loss, sensorineural Hearing loss resulting from damage to the sensory mechanism internal from the oval and round windows.
(12 Dec 1998)
sensorineural hearing loss <neurology> A form of deafness that occurs due to dysfunction of the auditory nerve (cranial nerve VIII).
(27 Sep 1997)
drift cyclotron loss cone instabilities (DCLC) This is an electrostatic microinstability (frequencies at harmonics of the ion cyclotron frequency) which is of major concern in small mirror devices. Mode is driven by radial gradients in the electron density, and causes loss of ions due to non-conservation of magnetic moment (see adiabatic invariant) as they interact with the mode, and are dispersed in velocity space into the loss cone. Stabilisation is accomplished by increasing the plasma size and by partially filling the loss cone with a continuous extermal warm plasma stream.
(09 Oct 1997)
eddy-current loss <radiobiology> Energy loss due to eddy currents circulating in a resistive material.
(09 Oct 1997)
tooth loss The failure to retain teeth as a result of disease or injury.
(12 Dec 1998)
functional visual loss An apparent loss of visual acuity or visual field with no substantiating physical signs; often due to a natural concern about visual loss combined with suggestibility and a fear of the worst; best treated with reassurance.
(05 Mar 2000)
loss cone In a magnetic mirror machine, particles with a large velocity parallel to the magneitc field and a small velocity perpendicular to the field will be able to escape past the magnetic mirror (see magnetic mirror). In that case the velocity distribution function (see distribution function) will be almost zero in the region of velocity space that allows particles to escape. The shape of that region (in a velocity space diagram with parallel velocity and perpendicular velocity as the axes) is a cone. When a particle undergoes a collision, its velocity gets somewhat randomised. Particles that are scattered into that cone are lost very quickly (in one mirror bounce time). Thus it is called a loss cone. Because of the loss cone, the theoretical maximum particle confinement time of a magnetic mirror machine can be only a few times the particle collision time, this is generally seen as a showstopper for mirror-based fusion research.
(09 Oct 1997)
loss of consciousness Total unresponsiveness. An important neurologic sign.
(27 Sep 1997)
loss of heterozygosity Refers to a mutation that results in the loss of allelic uniqueness, which is often defined as a greater than or equal to 40 percent increase in signal intensity of allelic signal. Loss of heterozygosity is most frequently identified in certain chromosome regions, including 5q, 17p, and 18q.
(12 Dec 1998)
atomic heat The amount of heat required to raise an atom from 0
radiant heat Heat given off from any body in the form of waves, similar to light waves but of greater wavelength.
(05 Mar 2000)
molar heat capacity <chemistry> The amount of energy required to raise the temperature of one mole of a substance by one degree Celsius (or Kelvin).
(09 Jan 1998)
molecular heat The product of the specific heat of a body multiplied by its molecular weight.
(05 Mar 2000)
combined heat and power An older term for what is now generally called cogeneration. The term is currently used in Europe and other foreign countries.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heat balance
    ¿­ÆòÇü
  • heat barrier
    (Ç×°ø±âÀÇ)¼Óµµ ÇѰèÁ¡(°ø±â¿Í ¸¶Âû¿­ Çѵµ)
  • heat capacity
    ¿­¿ë·®
  • heat consumption
    ¿­ ¼Òºñ·®
  • heat cramps
    ¿­ °æ·Ã(°í¿ÂÇÏÀÇ Á߳뵿À¸·Î ÀÎÇÑ)
  • heat engine
    ¿­±â°ü
  • heat exchange
    ¿­±³È¯
  • heat exchanger
    ¿­±³È¯±â
  • heat exhaustion
    ¿­»çº´
  • heat flash
    (ÇÙ Æø¹ß ¶§ÀÇ)°­·ÂÇÑ ¿­ ¹æ»ç
  • heat island
    ¿­¼¶(ÁÖº¯º¸´Ù ¿Âµµ°¡ ³ôÀº µµ½Ã(°ø¾÷ Áö´ë)
  • heat lamp
    Àû¿Ü¼±µî;žçµî
  • heat lightning
    (õµÕÀÌ ¾ø´Â)¸Õ °÷ÀÇ ¹ø°³
  • heat pollution
    ¿­°øÇØ
  • heat prostration
    =heat exhaustion
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á